Q4 2024 Management View CEO Jennifer Ernst highlighted significant advancements, including the acquisition of exclusive worldwide rights to the Phase III immunomodulatory drug candidate Entolimod, ...
The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.
Telix Pharmaceuticals Limited today announces that the United States Food and Drug Administration has approved its New Drug ...
As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...
The proposed merger would create a new ophthalmic company that combines two FDA-approved technologies: Betaliq's EyeSol ® water-free drug delivery technology for use in glaucoma, and Eyenovia's ...
Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...
A hair loss drug that first gained popularity in the 1990s is seeing a resurgence of interest. Minoxidil is best known as the ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback